je.st
news
Tag: portola
Portola Pharma and Williams skid, Office Depot and PVH climb
2016-03-24 23:24:26| Apparel - Topix.net
Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq stock market: The owner of the Calvin Klein and Tommy Hilfiger brands posted solid quarterly results and gave a strong outlook for 2016. The crane maker said Zoomlion, a Chinese competitor, raised its takeover offer to $31 per share from $30 a share.
Tags: office
williams
depot
climb
Portola: A Safe Harbor In The Choppy Waters Of Biotech Investing?
2016-03-05 04:40:44| Biotech - Topix.net
As we began 2015, investors could see choppy waters were appearing on the horizon for biotech stocks. Considering the spectacular run these stocks had over previous years, investor concerns were certainly in order.
Tags: safe
investing
waters
harbor
Portola Reports Q4, Updates Business Plans: Analysis Of This High-Risk Play
2016-03-02 23:40:43| Biotech - Topix.net
I first bought and wrote about Portola Pharmaceuticals in mid-2014, when the stock was revisiting its brief peak around $30 that it first hit in September 2013. It had IPO'ed in May at $15, so Friday's closing price of $27.79 still represents a successful IPO.
Tags: business
play
reports
analysis
Premarket Biotech Digest: Portola Insider Buying, Pfizer Advances Avelumab, Cara's Positive Data
2015-12-11 13:32:22| Biotech - Topix.net
Fullerton Management, a 10% owner in the company, raised its stake in PTLA. The insider purchase does not come as a surprise.
Tags: data
positive
buying
insider
Premarket Biotech Digest: Novartis Earnings, Portola Lawsuits, Celgene's Orphan Drug
2015-07-23 11:13:42| Biotech - Topix.net
Xarelto, Eliquis and other anticoagulants that face products liability lawsuits have made deals with Portola, which is developing an antidote. One of the first anticoagulants, warfarin, was used as rat poison for 50 years before it began life as a blood thinner - and the only reason it did that was because a US Army sergeant who tried to kill himself with it was cured when treated with Vitamin K. Moral of the story- if you want to develop an anticoagulant, you better also develop its antidote, or you could bungle your way into multiple lawsuits.
Tags: drug
earnings
digest
biotech